NATIONAL RESEARCH CORP (NRC)
US6373722023 - Common Stock
Taking everything into account, NRC scores 5 out of 10 in our fundamental rating. NRC was compared to 113 industry peers in the Health Care Providers & Services industry. NRC scores excellent points on both the profitability and health parts. This is a solid base for a good stock. NRC has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year NRC was profitable.
NRC had a positive operating cash flow in the past year.
NRC had positive earnings in each of the past 5 years.
In the past 5 years NRC always reported a positive cash flow from operatings.
1.2 Ratios
NRC has a better Return On Assets (24.57%) than 100.00% of its industry peers.
The Return On Equity of NRC (72.78%) is better than 96.46% of its industry peers.
NRC has a Return On Invested Capital of 36.55%. This is amongst the best in the industry. NRC outperforms 100.00% of its industry peers.
NRC had an Average Return On Invested Capital over the past 3 years of 38.44%. This is significantly above the industry average of 8.10%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.57% | ||
| ROE | 72.78% | ||
| ROIC | 36.55% |
ROA(3y)24.47%
ROA(5y)26.09%
ROE(3y)50.42%
ROE(5y)61.46%
ROIC(3y)38.44%
ROIC(5y)38.36%
1.3 Margins
NRC has a better Profit Margin (20.00%) than 100.00% of its industry peers.
NRC's Profit Margin has declined in the last couple of years.
NRC's Operating Margin of 27.11% is amongst the best of the industry. NRC outperforms 100.00% of its industry peers.
NRC's Operating Margin has declined in the last couple of years.
NRC has a better Gross Margin (61.92%) than 84.96% of its industry peers.
In the last couple of years the Gross Margin of NRC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.11% | ||
| PM (TTM) | 20% | ||
| GM | 61.92% |
OM growth 3Y-5.19%
OM growth 5Y-1.76%
PM growth 3Y-9.28%
PM growth 5Y-3.56%
GM growth 3Y-0.42%
GM growth 5Y0.68%
2. Health
2.1 Basic Checks
NRC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
NRC has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, NRC has less shares outstanding
NRC has a worse debt/assets ratio than last year.
2.2 Solvency
NRC has an Altman-Z score of 5.23. This indicates that NRC is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 5.23, NRC belongs to the best of the industry, outperforming 87.61% of the companies in the same industry.
The Debt to FCF ratio of NRC is 1.86, which is an excellent value as it means it would take NRC, only 1.86 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.86, NRC belongs to the top of the industry, outperforming 85.84% of the companies in the same industry.
A Debt/Equity ratio of 0.86 indicates that NRC is somewhat dependend on debt financing.
NRC's Debt to Equity ratio of 0.86 is on the low side compared to the rest of the industry. NRC is outperformed by 62.83% of its industry peers.
Even though the debt/equity ratio score it not favorable for NRC, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.86 | ||
| Debt/FCF | 1.86 | ||
| Altman-Z | 5.23 |
ROIC/WACC4.24
WACC8.62%
2.3 Liquidity
A Current Ratio of 0.37 indicates that NRC may have some problems paying its short term obligations.
NRC's Current ratio of 0.37 is on the low side compared to the rest of the industry. NRC is outperformed by 91.15% of its industry peers.
A Quick Ratio of 0.37 indicates that NRC may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.37, NRC is doing worse than 91.15% of the companies in the same industry.
The current and quick ratio evaluation for NRC is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.37 | ||
| Quick Ratio | 0.37 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 3.42% over the past year.
Measured over the past 5 years, NRC shows a small growth in Earnings Per Share. The EPS has been growing by 3.24% on average per year.
The Revenue has decreased by -1.47% in the past year.
NRC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.42% yearly.
EPS 1Y (TTM)3.42%
EPS 3Y-4.7%
EPS 5Y3.24%
EPS Q2Q%-10.34%
Revenue 1Y (TTM)-1.47%
Revenue growth 3Y3.68%
Revenue growth 5Y4.42%
Sales Q2Q%-3.15%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
NRC is valuated correctly with a Price/Earnings ratio of 16.08.
NRC's Price/Earnings ratio is rather cheap when compared to the industry. NRC is cheaper than 82.30% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.96. NRC is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.08 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NRC is valued a bit cheaper than 76.11% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, NRC is valued a bit cheaper than the industry average as 77.88% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.13 | ||
| EV/EBITDA | 10.74 |
4.3 Compensation for Growth
The excellent profitability rating of NRC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.96
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
NRC has a Yearly Dividend Yield of 2.53%.
Compared to an average industry Dividend Yield of 3.16, NRC pays a better dividend. On top of this NRC pays more dividend than 92.04% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.23, NRC has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.53% |
5.2 History
On average, the dividend of NRC grows each year by 16.85%, which is quite nice.
NRC has been paying a dividend for at least 10 years, so it has a reliable track record.
NRC has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)16.85%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
123.83% of the earnings are spent on dividend by NRC. This is not a sustainable payout ratio.
The dividend of NRC is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP123.83%
EPS Next 2YN/A
EPS Next 3YN/A
NATIONAL RESEARCH CORP
NASDAQ:NRC (11/21/2024, 8:00:01 PM)
After market: 19.46 0 (0%)19.46
+0.71 (+3.79%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap456.92M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.53% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.08 | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)4.96
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.57% | ||
| ROE | 72.78% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 27.11% | ||
| PM (TTM) | 20% | ||
| GM | 61.92% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.23
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.86 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.37 | ||
| Quick Ratio | 0.37 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)3.42%
EPS 3Y-4.7%
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.47%
Revenue growth 3Y3.68%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y